Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Javier E. Oesterheld, M.D.
Carolinas Medical Center, Levine Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- A.I. Dupont Hospital for Children, Delaware - Nemours
Wilmington, Delaware, United States
- Shand'S Hospital for Children at the University of Florida
Gainesville, Florida, United States
- Nemours Children'S Clinic
Jacksonville, Florida, United States
- Holtz Children'S Hospital at the University of Miami
Miami, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute, Coordinating Center
Tampa, Florida, United States
- University of Kentucky
Lexington, Kentucky, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Carolinas Medical Center, Levine Cancer Institute
Charlotte, North Carolina, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Vanderbilt - Ingram Cancer Center
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Oct 2016
- Primary completion
- 19 Nov 2024
- Completion
- 17 Feb 2025
- Last update posted
- 2 Apr 2026
- Registered enrollment
- 59
- Registry id
- NCT02945800
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.